These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2055046)

  • 21. Predicting disease progression in Alzheimer's disease: the role of neuropsychiatric syndromes on functional and cognitive decline.
    Palmer K; Lupo F; Perri R; Salamone G; Fadda L; Caltagirone C; Musicco M; Cravello L
    J Alzheimers Dis; 2011; 24(1):35-45. PubMed ID: 21157019
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early detection of isolated memory deficits in the elderly: the need for more sensitive neuropsychological tests.
    de Jager CA; Milwain E; Budge M
    Psychol Med; 2002 Apr; 32(3):483-91. PubMed ID: 11989993
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Longitudinal cognitive decline in patients with Alzheimer's disease.
    Rebok G; Brandt J; Folstein M
    J Geriatr Psychiatry Neurol; 1990; 3(2):91-7. PubMed ID: 2206264
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Most rapid cognitive decline in APOE epsilon4 negative Alzheimer's disease with early onset.
    van der Vlies AE; Koedam EL; Pijnenburg YA; Twisk JW; Scheltens P; van der Flier WM
    Psychol Med; 2009 Nov; 39(11):1907-11. PubMed ID: 19335933
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuropsychological prediction of decline to dementia in nondemented elderly.
    Kluger A; Ferris SH; Golomb J; Mittelman MS; Reisberg B
    J Geriatr Psychiatry Neurol; 1999; 12(4):168-79. PubMed ID: 10616864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regional atrophy is associated with impairment in distinct cognitive domains in Alzheimer's disease.
    Smits LL; Tijms BM; Benedictus MR; Koedam EL; Koene T; Reuling IE; Barkhof F; Scheltens P; Pijnenburg YA; Wattjes MP; van der Flier WM
    Alzheimers Dement; 2014 Oct; 10(5 Suppl):S299-305. PubMed ID: 24210526
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rate of cognitive change measured by neuropsychologic test performance in 3 distinct dementia syndromes.
    Wicklund AH; Rademaker A; Johnson N; Weitner BB; Weintraub S
    Alzheimer Dis Assoc Disord; 2007; 21(4):S70-8. PubMed ID: 18090428
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discriminative and predictive power of an informant report in mild cognitive impairment.
    Isella V; Villa L; Russo A; Regazzoni R; Ferrarese C; Appollonio IM
    J Neurol Neurosurg Psychiatry; 2006 Feb; 77(2):166-71. PubMed ID: 16421116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Smell identification function as a severity and progression marker in Alzheimer's disease.
    Velayudhan L; Pritchard M; Powell JF; Proitsi P; Lovestone S
    Int Psychogeriatr; 2013 Jul; 25(7):1157-66. PubMed ID: 23597130
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Top cited papers in International Psychogeriatrics: 6c. Tracking cognitive decline in Alzheimer's disease using the Mini-mental State Examination: a meta-analysis ("mini" is not necessarily trivial!).
    Han L
    Int Psychogeriatr; 2009 Dec; 21(6):1037-40. PubMed ID: 19747422
    [No Abstract]   [Full Text] [Related]  

  • 31. Instability of cognitive asymmetry in Alzheimer's disease.
    Xeno Rasmusson D; Brandt J
    J Clin Exp Neuropsychol; 1995 May; 17(3):449-58. PubMed ID: 7650106
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selected psychiatric symptoms associated with rate of cognitive decline in patients with Alzheimer's disease.
    Miller TP; Tinklenberg JR; Brooks JO; Fenn HH; Yesavage JA
    J Geriatr Psychiatry Neurol; 1993; 6(4):235-8. PubMed ID: 8251053
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cognitive decline in Alzheimer's disease: elaborating on the nature of the longitudinal factor structure of the Mini-Mental State Examination.
    Brooks JO; Yesavage JA; Taylor J; Friedman L; Tanke ED; Luby V; Tinklenberg J
    Int Psychogeriatr; 1993; 5(2):135-46. PubMed ID: 8292767
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Concurrent validity of Spanish-language versions of the Mini-Mental State Examination, Mental Status Questionnaire, Information-Memory-Concentration test, and Orientation-Memory-Concentration test: Alzheimer's disease patients and nondemented elderly comparison subjects.
    Taussig IM; Mack WJ; Henderson VW
    J Int Neuropsychol Soc; 1996 Jul; 2(4):286-98. PubMed ID: 9375177
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regional quantification of white matter hyperintensity in normal aging, mild cognitive impairment, and Alzheimer's disease.
    Chen YF; Wang H; Chu Y; Huang YC; Su MY
    Dement Geriatr Cogn Disord; 2006; 22(2):177-84. PubMed ID: 16912479
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Utility of combinations of biomarkers, cognitive markers, and risk factors to predict conversion from mild cognitive impairment to Alzheimer disease in patients in the Alzheimer's disease neuroimaging initiative.
    Gomar JJ; Bobes-Bascaran MT; Conejero-Goldberg C; Davies P; Goldberg TE;
    Arch Gen Psychiatry; 2011 Sep; 68(9):961-9. PubMed ID: 21893661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The influence of handedness on the clinical presentation and neuropsychology of Alzheimer disease.
    Doody RS; Vacca JL; Massman PJ; Liao TY
    Arch Neurol; 1999 Sep; 56(9):1133-7. PubMed ID: 10488815
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical predictors of progression to Alzheimer disease in amnestic mild cognitive impairment.
    Fleisher AS; Sowell BB; Taylor C; Gamst AC; Petersen RC; Thal LJ;
    Neurology; 2007 May; 68(19):1588-95. PubMed ID: 17287448
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Education and rates of cognitive decline in incident Alzheimer's disease.
    Scarmeas N; Albert SM; Manly JJ; Stern Y
    J Neurol Neurosurg Psychiatry; 2006 Mar; 77(3):308-16. PubMed ID: 16484637
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rate of cognitive change in Alzheimer's disease: methodological approaches using random effects models.
    Gould R; Abramson I; Galasko D; Salmon D
    J Int Neuropsychol Soc; 2001 Nov; 7(7):813-24. PubMed ID: 11771624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.